Result of EGM

 

TIDMAVCT TIDMCUR 
 
RNS Number : 0135N 
Avacta Group PLC 
09 February 2009 
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR 
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE 
RELEVANT LAWS OF SUCH JURISDICTION 
 
 
London, 9 February 2009 
 
 
Avacta Group plc ("Avacta") 
 
 
Offer Update: Result of Shareholder Meeting 
 
 
The Avacta Board is pleased to announce that, at the Avacta General Meeting held 
earlier today in relation to 
the recommended offer for Curidium Medica plc ("Curidium") by Avacta (the 
"Proposed Acquisition"), the Avacta Resolutions necessary to effect the Proposed 
Acquisition were passed by the requisite majorities. 
The number of proxy votes lodged for each resolution before the meeting was as 
follows: 
+----------------------+-------------+---------+---------+---------+------------+ 
|                      | Total For*            | Total Against     | Votes      | 
|                      |                       |                   | Withheld   | 
+----------------------+-----------------------+-------------------+------------+ 
| Resolution           | No. of      | %age of | No. of  | %age of | No. of     | 
|                      | votes       | vote    | votes   | vote    | votes      | 
+----------------------+-------------+---------+---------+---------+------------+ 
| 1. To allot equity   | 297,483,904 | 98.6    | 60,000  | 0.02    | 0          | 
| securities in        |             |         |         |         |            | 
| connection with the  |             |         |         |         |            | 
| Scheme               |             |         |         |         |            | 
+----------------------+-------------+---------+---------+---------+------------+ 
| 2. To adopt the EMI  | 297,543,904 | 98.6    | 0       | 0       | 0          | 
| Scheme               |             |         |         |         |            | 
+----------------------+-------------+---------+---------+---------+------------+ 
 
 *Figures do not include discretionary votes. 
Implementation of the Scheme of Arrangement remains conditional upon the 
approval by Curidium Scheme Shareholders of the resolutions at the Curidium 
General Meeting and of the Scheme of Arrangement at the Court Meeting, both of 
which are due to be held on 11 February 2009, and the satisfaction or (where 
applicable) waiver of the other Conditions set out in the Scheme Document posted 
to Curidium Shareholders on 16 January 2009. 
On the basis that the Curidium resolutions are passed and that the Court 
sanctions the Scheme of Arrangement and confirms the associated Reduction of 
Capital at the Court Hearing scheduled to take place on 2 March 2009, it is 
anticipated that, on 3 March 2009 the Scheme will become effective and that 
dealings in the New Avacta Shares will commence on 4 March 2009. New Avacta 
Shares will be credited to CREST accounts on the same date. It is expected that 
share certificates for New Avacta Shares will be dispatched by no later than 17 
March 2009. 
Copies of the Avacta Resolutions passed at the Avacta General Meeting will be 
available for inspection by the public from tomorrow at the offices of Avacta at 
York Biocentre, York Science Park, Innovation Way, Heslington, York YO10 5NY and 
also those of Walker Morris situated at: Kings Court, 12 Kings Street, Leeds LS1 
2HL during normal business hours on any weekday (public holidays excepted) until 
4 March 2009. 
Terms used but not defined in this announcement shall have the same meaning as 
in the Scheme Document dated 16 January 2009. 
 
 
 
 
Enquiries 
 
 
Avacta 
Dr Alastair Smith, Chief Executive Officer 
Tim Sykes, Chief Financial Officer 
Tel: [phone] 
 
 
Curidium 
Dr. Barry Porter, Chairman 
Rob Smith, Chief Financial Officer 
Tel: [phone] 
 
 
Novum Securities Limited (financial adviser to Avacta) 
Henry Turcan 
Tel: [phone] 
 
 
FinnCap (financial adviser to Curidium) 
Charlie Cunningham 
Tel: [phone] 
 
 
Haggie Financial (PR to Avacta) 
Nicholas Nelson 
Tel: [phone] 
 
 
Novum Securities Limited, which is authorised and regulated in the UK by the 
Financial Services Authority, is acting as financial adviser to Avacta in 
connection with the Recommended Offer and no-one else and will not be 
responsible to anyone other than Avacta for providing the protections afforded 
to clients of Novum Securities nor for providing advice in relation to the 
Recommended Offer nor any other matter referred to in this announcement. 
 
 
FinnCap, which is authorised and regulated in the UK by the Financial Services 
Authority, is acting as financial adviser and broker to Curidium in connection 
with the Recommended Offer and no-one else and will not be responsible to anyone 
other than Curidium for providing the protections afforded to clients of FinnCap 
nor for providing advice in relation to the Recommended Offer nor any other 
matter referred to in this announcement. 
 
 
 
 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 REGEAAANEDPNEFE